Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

How do antiplatelet agents compare in preventing strokes or transient ischemic attacks?

0
Posted

How do antiplatelet agents compare in preventing strokes or transient ischemic attacks?

0

Dipyridamole ER-plus-aspirin may be superior to aspirin alone in reducing the risk of stroke in patients who have already had an ischemic stroke or a transient ischemic attack (NNT=33 in one study, but insignificant difference in another study). Headache and gastrointestinal adverse events were more common with dipyridamole ER-plus-aspirin compared to aspirin alone, but the risk of major bleeding was not increased. Ticlopidine is also superior to aspirin in preventing recurrent strokes (NNT=40) with the exception of African American patients, who show no difference. GI bleeding was less common in patients taking ticlopidine, but patients were more likely to develop diarrhea (NNH=10), a rash (NNH=16), or neutropenia (NNH=50). Clopidogrel, alone or with aspirin, has not been found to be beneficial in reducing the risk of stroke compared to aspirin alone, but clopidogrel-plus-aspirin was associated with higher rates of major bleeding.

Related Questions

Thanksgiving questions

*Sadly, we had to bring back ads too. Hopefully more targeted.